▮ Entertainment

Top Stories
Slide Shows
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ More

Wall Street Events

Plus

Neg

Email

Twenty-First Century Fox Q2 20 Earnings Conference Call At 4:30 PM ET

By RTTNews Staff Writer ✉ | Published: 2/5/2020 6:07 AM ET

Twenty-First Century Fox, Inc. (FOX) will host a conference call at 4:30 PM ET on Feb. 5, 2020, to discuss its Q2 20 earnings results.

To access the live webcast, log on at investor.foxcorporation.com

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2020 COVID19 papulopustular rosacea pneumonia NASH NMOSD Keytruda follicular lymphoma

Biotech Stocks Facing FDA Decision In June 2020

Countries that tamed coronavirus

Countries that tamed coronavirus

The 1918 Spanish Flu Pandemic

The 1918 Spanish Flu Pandemic

Latest Updates on COVID-19

First Covid-19 Contact Tracing App With Apple-Google Technology Launched

Merck Inks Deals, Joins Coronavirus Vaccine Race

US Coronavirus Infections Rise For Third Day; To Above 25000

Global COVID-19 Cases Top 5 Million

Coronavirus Daily Infection Rate Returns To 20000-plus Mark In US

Countries that tamed coronavirus

Read More

COVID-19: Drugs in Development

RELATED NEWS

Fox Corporation Q3 adjusted earnings Beat Estimates

Fox Corp. To Buy Streaming Service Tubi For $440 Mln In Cash

Follow RTT

Editor's Pick
Most Read
Most Emailed

Target, Walmart, CVS Close Stores Amid George Floyd Protests

Nestle USA Recalls Lean Cuisine Fettuccini Alfredo Products

Apple CEO Condemns Killing Of George Floyd; Says Racial Injustice Exists In U.S.

Apotex Recalls Diabetes Drug Metformin HCL Extended-Release Tablets

Renault Plans To Cut About 14,600 Jobs Worldwide

Amazon To Convert 125,000 Temporary Workers To Permanent Roles

Mitsubishi Recalls Vehicles For Suspension Rust Problem

Arizona Files Consumer Fraud Lawsuit Against Google

Boeing Lays Off 6,770 Employees; Resumes 737 MAX Production

Dollar Tree Q1 Results Top Estimates; Does Not Issue Outlook

Sanvall Recalls Rapid Alivio Pain Relieving Roll-On

FDA Approves Lilly's Cyramza To Treat Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

The Week That Was: MRK Enters COVID Space, GSK's 1Bln Dose Target, Roche, GILD Team Up For REMDACTA

Stock Alert: Phio Pharma Shares Soar 125%

Boston Properties Issues Update On May Rent Collections - Quick Facts

Pliant Therapeutics To Debut On Nasdaq On June 3

Pfizer Says Breast Cancer Trial Unlikely To Be Effective

At The ASCO: ONCY, IMV, CRDF, GILD, TAK…

Apotex Recalls Diabetes Drug Metformin HCL Extended-Release Tablets

Pfizer, Astellas Say Final PROSPER Results Show XTANDI Extends Overall Survival

ABIO Jumps On Joining COVID-19 Drug Fray, GMAB Hits Trial Goal, IMRA On Watch

PHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On Watch

Novartis To Begin Making Potential Coronavirus Vaccine

California Utility Regulators Approves PG&E's Chapter 11 Reorganization Plan

Trip.com Slips To Loss In Q1

Costco Wholesale Corporation Reports Fall In Q3 Earnings

Stock Alert: Dollar Tree Climbs 11%

Conformis Settles Patent Dispute With Zimmer Biomet - Quick Facts

EARNINGS SUMMARY: Details of Canadian Solar Inc. Q1 Earnings Report

Triumph Group Inc. Q4 adjusted earnings Beat Estimates

Fresenius Kabi, Medac Signs Marketing Deal For Biosimilar Product - Quick Facts

Stock Alert: PhaseBio Shares Jump 82% In Late Trade On FDA Nod For COVID-19 Clinical Trial

Bodycote 4-month Revenue Down 12%

FirstGroup Welcomes Finalization Of Further Funding Programme From U.K. Transport Dept.

Genentech Initiates Phase III Trial Of Actemra Plus Remdesivir On Severe COVID-19 Pneumonia